Charlotte M. J. Wesseling

ORCID: 0000-0003-0907-4498
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Antimicrobial Peptides and Activities
  • Antibiotics Pharmacokinetics and Efficacy
  • Microbial Natural Products and Biosynthesis
  • Biochemical and Structural Characterization
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Antimicrobial agents and applications
  • Protein Degradation and Inhibitors
  • Peptidase Inhibition and Analysis
  • Bacterial Genetics and Biotechnology
  • Bacterial biofilms and quorum sensing
  • Synthesis and Catalytic Reactions
  • Ubiquitin and proteasome pathways
  • Antibiotic Use and Resistance

Leiden University
2017-2023

Brevicidine and laterocidine are two recently discovered lipopeptide antibiotics with promising antibacterial activity. Possessing a macrocyclic core, multiple positive charges, lipidated N-terminus, these lipopeptides exhibit potent selective activity against Gram-negative pathogens, including polymyxin-resistant isolates. Given the low amounts of brevicidine accessible by fermentation producing microorganisms, synthetic routes to present an attractive alternative. We here report convenient...

10.1039/d2sc00143h article EN cc-by Chemical Science 2022-01-01

With increasing rates of resistance toward commonly used antibiotics, especially among Gram-negative bacteria, there is renewed interested in polymyxins. Polymyxins are lipopeptide antibiotics with potent anti-Gram-negative activity and generally believed to target lipid A, the lipopolysaccharide (LPS) anchor found outer membrane bacteria. To characterize stereochemical aspects their mechanism(s) action, we synthesized full enantiomers polymyxin B nonapeptide (PMBN). Both compounds were...

10.1021/acsinfecdis.2c00307 article EN cc-by ACS Infectious Diseases 2022-11-07

Pentamidine, an FDA-approved antiparasitic drug, was recently identified as outer membrane disrupting synergist that potentiates erythromycin, rifampicin, and novobiocin against Gram-negative bacteria. The same study also described a preliminary structure-activity relationship using commercially available pentamidine analogues. We here report the design, synthesis, evaluation of broader panel bis-amidines inspired by pentamidine. present both validates previously observed synergistic...

10.1021/acsinfecdis.1c00466 article EN cc-by-nc-nd ACS Infectious Diseases 2021-11-12

Polymyxins are a class of lipopeptide anti-infective agents with potent and specific activity against Gram-negative bacteria. While toxicity concerns associated polymyxin B E (colistin) have historically limited their clinical application, today they increasingly used as last-resort antibiotics given the rise multidrug-resistant pathogens. The adverse side effects polymyxins well known, particularly related to nephrotoxicity. Here, we describe synthesis evaluation novel series analogues,...

10.1021/acs.jmedchem.2c01528 article EN cc-by Journal of Medicinal Chemistry 2022-11-18

In the hunt for new antibiotics with activity against Gram-negative pathogens, outer membrane β-barrel assembly machine (BAM) complex has become an increasingly interesting target. The recently reported BAM inhibitor, MRL-494, was discovered via a screening campaign molecules that target membrane. Notably, MRL-494 to be unintended byproduct generated during synthesis of unrelated compound, and as such no compound disclosed. We here present convenient reliable route scales well. antibacterial...

10.1021/acsinfecdis.2c00459 article EN cc-by ACS Infectious Diseases 2022-11-01

The continued rise of antibiotic resistance threatens to undermine the utility world’s current arsenal. This problem is particularly troubling when it comes Gram-negative pathogens for which there are inherently fewer antibiotics available. To address this challenge, recent attention has been focused on finding compounds capable disrupting outer membrane as a means potentiating otherwise Gram-positive-specific antibiotics. In regard, agents binding lipopolysaccharide (LPS) present in...

10.3390/molecules26071954 article EN cc-by Molecules 2021-03-30

Most known β2-selective proteasome inhibitors suffer from relatively poor cell permeability as the result of a net positive charge caused by basic moiety at P1. In this paper, we describe synthesis oligopeptide vinyl sulfones that contain different amino acids bearing groups with reduced basicity P1 and/or P3. For this, developed first enantioselective lysine(4-ene) and lysine(4-yne). These acids, well histidine diaminopropionic-acid-glycine, were incorporated P3 positions sulfones. All...

10.1002/ejoc.201701174 article EN European Journal of Organic Chemistry 2017-09-12

A novel series of polymyxin analogues bearing a disulfide linked lipid tail are reported. The most promising variant identified exhibits antibacterial activity equipotent to that B and is >10-fold less toxic towards kidney cells.

10.1039/d3md00456b article EN RSC Medicinal Chemistry 2023-01-01

Brevicidine and laterocidine are two recently discovered lipopeptide antibiotics with promising antibacterial activity. Possessing a macrocyclic core, multiple positive charges, lipidated N-terminus, these lipopeptides exhibit potent selective activity against Gram-negative pathogens, including polymyxin-resistant isolates. Given the low amounts of brevicidine accessible by fermentation producing microorganisms, synthetic routes to present an attractive alternative. We here report convenient...

10.26434/chemrxiv-2022-15r0h-v2 preprint EN cc-by-nc-nd 2022-01-10
Coming Soon ...